Compare CCO & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCO | WGS |
|---|---|---|
| Founded | 1995 | 2017 |
| Country | United States | United States |
| Employees | N/A | 1300 |
| Industry | Advertising | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2005 | N/A |
| Metric | CCO | WGS |
|---|---|---|
| Price | $2.40 | $60.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $2.12 | ★ $120.71 |
| AVG Volume (30 Days) | ★ 7.3M | 1.3M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 110.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,604,140,000.00 | N/A |
| Revenue This Year | $5.35 | $29.98 |
| Revenue Next Year | $4.26 | $25.92 |
| P/E Ratio | ★ N/A | $1,251.58 |
| Revenue Growth | ★ 6.57 | N/A |
| 52 Week Low | $1.00 | $32.21 |
| 52 Week High | $2.43 | $170.87 |
| Indicator | CCO | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 61.72 |
| Support Level | $2.37 | $56.24 |
| Resistance Level | $2.41 | $73.46 |
| Average True Range (ATR) | 0.01 | 3.92 |
| MACD | -0.00 | 1.73 |
| Stochastic Oscillator | 25.00 | 83.83 |
Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.